The prevention and genetics of pancreatic cancer: A programmatic approach

Methods in Molecular Biology

Volumn 980, Issue , 2013, Pages 205-214

  Lucas, Aimee L ^a   Chang, Michelle M ^a   Lipsyc, Marla D ^a   Frucht, Harold ^a  

^a NONE

Author keywords

Biorepository; Cancer prevention; Database; Genetic testing; Hereditary pancreatic cancer; Pancreatic cancer; Registry; Screening; Surveillance; Tissue bank

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; MISMATCH REPAIR PROTEIN PMS2; PROTEIN KINASE LKB1; PROTEIN MLH1; PROTEIN MSH6; PROTEIN P16; PRSS1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER PREVENTION; CANCER SCREENING; DISEASE PREDISPOSITION; EARLY DIAGNOSIS; FAMILIAL CANCER; FAMILY HISTORY; FIRST DEGREE RELATIVE; GENE MUTATION; GENETIC SCREENING; HISTORY; HUMAN; HUMAN TISSUE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; QUESTIONNAIRE; FACTUAL DATABASE; GENETIC PREDISPOSITION; GENETICS; HEALTH CARE FACILITY; PANCREAS TUMOR; RISK ASSESSMENT;

BIOLOGICAL SPECIMEN BANKS; DATABASES, FACTUAL; EARLY DETECTION OF CANCER; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; PANCREATIC NEOPLASMS; QUESTIONNAIRES; RISK ASSESSMENT;

MLCS; MLOWN;

EID: 84879587334     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-287-2_10     Document Type: Article

References (41)

1. Michaud DS (2004) Epidemiology of pancreatic cancer. Minerva Chir 59:99-111
2. American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society; 2012
3. Brand RE et al (2007) Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 56:1460-1469
4. Kohler BA et al (2011) Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 103:714-736
5. Langer P et al (2009) Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer. Gut 58: 1410-1418
6. Verna EC et al (2010) Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics. Clin Cancer Res 16:5028-5037
7. Kimmey MB et al (2002) Screening and surveillance for hereditary pancreatic cancer. Gastrointest Endosc 56:S82-S86
8. Canto MI et al (2004) Screening for pancreatic neoplasia in high-risk individuals: an EUSbased approach. Clin Gastroenterol Hepatol 2:606-621
9. Poley JW et al (2009) The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol 104: 2175-2181
10. Ghadirian P et al (1991) Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol 10:183-196
11. Tersmette AC et al (2001) Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 7:738-744
12. Falk RT, Pickle LW, Fontham ET, Correa P, Fraumeni JF Jr (1988) Life-style risk factors for pancreatic cancer in Louisiana: a case-control study. Am J Epidemiol 128:324-336
13. Fernandez E, La Vecchia C, D'Avanzo B, Negri E, Franceschi S (1994) Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 3:209-212
14. Silverman DT, Schiffman M, Everhart J, Goldstein A et al (1999) Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 80:1830-1837
15. Grover S, Syngal S (2010) Hereditary pancreatic cancer. Gastroenterology 139:1076-1080, 1080 e1071-1072
16. Lynch HT, Fusaro RM (1991) Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome. Pancreas 6: 127-131
17. Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN et al (2000) Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119:1447-1453
18. Lowenfels AB, Maisonneuve P, DiMagno EP et al (1997) Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 89:442-446
19. Schneider R, Slater EP, Sina M et al (2011) German national case collection for familial pancreatic cancer (FaPaCa): ten years experience. Fam Cancer 10:323-330
20. Jones S, Hruban RH, Kamiyama M, Borges M et al (2009) Exomic sequencing identi fies PALB2 as a pancreatic cancer susceptibility gene. Science 324:217
21. Lynch HT, Smyrk T, Kern SE, Hruban RH et al (1996) Familial pancreatic cancer: a review. Semin Oncol 23:251-275
22. Evans JP, Burke W, Chen R, Bennett RL et al (1995) Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis. J Med Genet 32:330-335
23. Hruban RH, Petersen GM, Ha PK, Kern SE (1998) Genetics of pancreatic cancer. From genes to families. Surg Oncol Clin N Am 7:1-23
24. Hahn SA, Greenhalf B, Ellis I, Sina-Frey M et al (2003) BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 95:214-221
25. Lynch HT, Brand RE, Deters CA et al (2001) Hereditary pancreatic cancer. Pancreatology 1:466-471
26. Applebaum SE, Kant JA, Whitcomb DC, Ellis IH (2000) Genetic testing. Counseling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases. Med Clin North Am 84:575-588, viii
27. Klein AP, Beaty TH, Bailey-Wilson JE, Brune KA, Hruban RH, Petersen GM (2002) Evidence for a major gene in fluencing risk of pancreatic cancer. Genet Epidemiol 23: 133-149
28. Schenk M, Schwartz AG, O'Neal E, Kinnard M et al (2001) Familial risk of pancreatic cancer. J Natl Cancer Inst 93:640-644
29. Real FX (2003) A "catastrophic hypothesis" for pancreas cancer progression. Gastroenterology 124:1958-1964
30. Hruban RH, Adsay NV, Albores-Saavedra J, Compton C et al (2001) Pancreatic intraepithelial neoplasia: a new nomenclature and classi fication system for pancreatic duct lesions. Am J Surg Pathol 25:579-586
31. Del Chiaro M, Zerbi A, Capurso G, Zamboni G et al (2010) Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry. Dig Liver Dis 42:597-605
32. Brune K, Abe T, Canto M, O'Malley L, Klein AP et al (2006) Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol 30:1067-1076
33. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C et al (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17-32
34. Tanaka M, Fernandez-del Castillo C, Adsay V, et al (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12:183-97.
35. Sipos B, Frank S, Gress T, Hahn S, Kloppel G (2009) Pancreatic intraepithelial neoplasia revisited and updated. Pancreatology 9: 45-54
36. Ariyama J, Suyama M, Satoh K, Sai J (1998) Imaging of small pancreatic ductal adenocarcinoma. Pancreas 16:396-401
37. Hudson KL (2011) Genomics, health care, and society. N Engl J Med 365:1033-1041
38. Canto MI, Harinck F, Hruban RH, et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 2012
39. O.H.R.P 2008 Protections. Guidance on Research Involving Coded Private Information or Biological Specimens
40. Farnell MB (2008) Surgical management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. J Gastrointest Surg 12:414-416
41. Walsh RM, Henderson JM, Vogt DP, Baker ME et al (2002) Prospective preoperative determination of mucinos pancreatic cystic neoplasms. Surgery 132:628-633, discussion 633-624